 |
|
Stroke and the Risk of Alzheimer Disease
Lawrence S. Honig, MD, PhD;
Ming-Xin Tang, PhD;
Steven Albert, PhD, MSc;
Rosanne Costa, MA;
Jose Luchsinger, MD;
Jennifer Manly, PhD;
Yaakov Stern, PhD;
Richard Mayeux, MD, MSc
Arch Neurol. 2003;60:1707-1712.
Background Alzheimer disease (AD) and stroke are common in elderly individuals, but the relation between these 2 disorders remains uncertain.
Objective To investigate the association between a clinical history of stroke and subsequent risk of AD.
Design A cohort of 1766 Medicare recipients without dementia participated in a longitudinal follow-up study from 1992 through 1999 in upper Manhattan, New York, NY. History of stroke and presence of cardiovascular risk factors were ascertained at the onset of the study. Incidence rates for AD among those with and without stroke were calculated; proportional hazards ratios were computed using age at onset of the disease as the time-to-event variable.
Results The annual incidence for AD was 5.2% among individuals with stroke vs 4% for those without stroke. The hazards ratio for AD among those with a history of stroke was 1.6 (95% confidence interval, 1.0-2.4) compared with those without stroke. Of the vascular risk factors, hypertension, diabetes, and heart disease, only diabetes related to risk of AD in the absence of stroke. Stroke remained weakly associated with AD in the absence of these factors, but risk significantly increased with the additional factors of hypertension (relative risk, 2.3; 95% confidence interval, 1.4-3.6), diabetes (relative risk, 4.6; 95% confidence interval, 2.2-9.5), or heart disease (relative risk, 2.0; 95% confidence interval, 1.2-3.2).
Conclusions Stroke is associated with AD among elderly individuals. The relation is strongest in the presence of known vascular risk factors. The observed association between stroke and AD might relate to an underlying systemic vascular disease process, or alternatively, to the additive effects of stroke and AD pathologic features, leading to an earlier age at onset of disease.
From the Taub Institute for Research on Alzheimer's Disease and the Aging Brain (Drs Honig, Luchsinger, Manly, Stern, and Mayeux), the Gertrude H. Sergievsky Center (Drs Honig, Tang, Albert, Luchsinger, Manly, Stern, and Mayeux and Ms Costa), and the Departments of Neurology
(Drs Honig, Albert, Manly, Stern, and Mayeux), Medicine (Dr Luchsinger), Psychiatry (Drs Stern and Mayeux), Biostatistics/Public Health
(Dr Tang), and Epidemiology/Public Health (Dr Mayeux), Columbia University College of Physicians and Surgeons.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
RELATED LETTERS
Stroke and Memory Decline: A Question of Degenerative or Vascular Origin
Francesco Panza, Cristiano Capurso, and Vincenzo Solfrizzi
Arch Neurol. 2006;63(9):1347-1348.
EXTRACT
| FULL TEXT
Stroke and Memory Decline: A Question of Degenerative or Vascular Origin—Reply
Christiane Reitz, José A. Luchsinger, and Richard Mayeux
Arch Neurol. 2006;63(9):1348.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
Patients With Alzheimer Disease Have Altered Transmitral Flow: Echocardiographic Analysis of the Vortex Formation Time
Belohlavek et al.
J Ultrasound Med 2009;28:1493-1500.
ABSTRACT
| FULL TEXT
Subclinical cerebrovascular disease in mild cognitive impairment
Luchsinger et al.
Neurology 2009;73:450-456.
ABSTRACT
| FULL TEXT
Contribution of Vascular Risk Factors to the Progression in Alzheimer Disease
Helzner et al.
Arch Neurol 2009;66:343-348.
ABSTRACT
| FULL TEXT
Vascular risk factors and dementia: How to move forward?
Viswanathan et al.
Neurology 2009;72:368-374.
ABSTRACT
| FULL TEXT
Assessing the Impact of Vascular Disease in Demented and Nondemented Patients
Libon and Heilman
Stroke 2008;39:783-784.
FULL TEXT
Vascular factors predict rate of progression in Alzheimer disease
Mielke et al.
Neurology 2007;69:1850-1858.
ABSTRACT
| FULL TEXT
Disease-modifying therapies for Alzheimer disease: Challenges to early intervention
Cummings et al.
Neurology 2007;69:1622-1634.
ABSTRACT
| FULL TEXT
Lacunar lesions are independently associated with disability and cognitive impairment in CADASIL
Viswanathan et al.
Neurology 2007;69:172-179.
ABSTRACT
| FULL TEXT
Relation of Diabetes to Mild Cognitive Impairment
Luchsinger et al.
Arch Neurol 2007;64:570-575.
ABSTRACT
| FULL TEXT
Relation of Higher Folate Intake to Lower Risk of Alzheimer Disease in the Elderly
Luchsinger et al.
Arch Neurol 2007;64:86-92.
ABSTRACT
| FULL TEXT
Mediterranean Diet, Alzheimer Disease, and Vascular Mediation
Scarmeas et al.
Arch Neurol 2006;63:1709-1717.
ABSTRACT
| FULL TEXT
Stroke and Memory Decline: A Question of Degenerative or Vascular Origin--Reply
Reitz et al.
Arch Neurol 2006;63:1348-1348.
FULL TEXT
Stroke and memory decline: a question of degenerative or vascular origin.
Panza et al.
Arch Neurol 2006;63:1347-1348.
FULL TEXT
Stroke and memory performance in elderly persons without dementia.
Reitz et al.
Arch Neurol 2006;63:571-576.
ABSTRACT
| FULL TEXT
Familial Alzheimer disease in Latinos: Interaction between APOE, stroke, and estrogen replacement
Rippon et al.
Neurology 2006;66:35-40.
ABSTRACT
| FULL TEXT
White Matter Lesions Are Prevalent but Differentially Related With Cognition in Aging and Early Alzheimer Disease
Burns et al.
Arch Neurol 2005;62:1870-1876.
ABSTRACT
| FULL TEXT
Physical Activity, Cognitive Activity, and Cognitive Decline in a Biracial Community Population
Sturman et al.
Arch Neurol 2005;62:1750-1754.
ABSTRACT
| FULL TEXT
Blood Pressure Lowering in PROGRESS (Perindopril Protection Against Recurrent Stroke Study) and White Matter Hyperintensities: Should This Progress Matter to Patients?
Schiffrin
Circulation 2005;112:1525-1526.
FULL TEXT
Aggregation of vascular risk factors and risk of incident Alzheimer disease
Luchsinger et al.
Neurology 2005;65:545-551.
ABSTRACT
| FULL TEXT
Advanced glycation end products and RAGE: a common thread in aging, diabetes, neurodegeneration, and inflammation
Ramasamy et al.
Glycobiology 2005;15:16R-28R.
ABSTRACT
| FULL TEXT
Statins Cause Intracellular Accumulation of Amyloid Precursor Protein, {beta}-Secretase-cleaved Fragments, and Amyloid {beta}-Peptide via an Isoprenoid-dependent Mechanism
Cole et al.
J. Biol. Chem. 2005;280:18755-18770.
ABSTRACT
| FULL TEXT
Atherosclerosis and AD: Analysis of data from the US National Alzheimer's Coordinating Center
Honig et al.
Neurology 2005;64:494-500.
ABSTRACT
| FULL TEXT
Mixed Dementia: Emerging Concepts and Therapeutic Implications
Langa et al.
JAMA 2004;292:2901-2908.
ABSTRACT
| FULL TEXT
Preventing Dementia by Treating Hypertension and Preventing Stroke
Spence
Hypertension 2004;44:20-21.
FULL TEXT
Self- or Proxy-Reported Stroke and the Risk of Alzheimer Disease
Hayden et al.
Arch Neurol 2004;61:982-982.
FULL TEXT
Self- or Proxy-Reported Stroke and the Risk of Alzheimer Disease--Reply
Honig and Mayeux
Arch Neurol 2004;61:983-983.
FULL TEXT
Are Patients With Cognitive Impairment After Stroke at Increased Risk for Developing Alzheimer Disease?
Talelli and Ellul
Arch Neurol 2004;61:983-983.
FULL TEXT
Are Patients With Cognitive Impairment After Stroke at Increased Risk for Developing Alzheimer Disease?--Reply
Honig and Mayeux
Arch Neurol 2004;61:983-984.
FULL TEXT
|
